Safety, Efficacy, and Tumor Immune Microenvironment Changes with Neoadjuvant Chemotherapy and Cemiplimab with or without Alirocumab in Stage 1B-3A Non-Small Cell Lung Cancer
Clinical Trial Grant
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
August 28, 2024
End Date
July 31, 2030
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
August 28, 2024
End Date
July 31, 2030